Mutant p53-Notch1 Signaling Axis Is Involved in Curcumin-Induced Apoptosis of Breast Cancer Cells.
10.4196/kjpp.2013.17.4.291
- Author:
Yun Hee BAE
1
;
Jong Hyo RYU
;
Hyun Joo PARK
;
Kwang Rok KIM
;
Hee Jun WEE
;
Ok Hee LEE
;
Hye Ock JANG
;
Moon Kyoung BAE
;
Kyu Won KIM
;
Soo Kyung BAE
Author Information
1. Department of Dental Pharmacology, School of Dentistry, Yangsan Campus of Pusan National University, Yangsan 626-870, Korea. skbae@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Apoptosis;
Breast cancer cells;
Curcumin;
Mutant p53;
Notch1
- MeSH:
Apoptosis;
Axis, Cervical Vertebra;
Breast;
Breast Neoplasms;
Chromatin Immunoprecipitation;
Curcumin;
Down-Regulation;
Humans;
RNA, Small Interfering
- From:The Korean Journal of Physiology and Pharmacology
2013;17(4):291-297
- CountryRepublic of Korea
- Language:English
-
Abstract:
Notch1 has been reported to be highly expressed in triple-negative and other subtypes of breast cancer. Mutant p53 (R280K) is overexpressed in MDA-MB-231 triple-negative human breast cancer cells. The present study aimed to determine whether the mutant p53 can be a potent transcriptional activator of the Notch1 in MDA-MB-231 cells, and explore the role of this mutant p53-Notch1 axis in curcumin-induced apoptosis. We found that curcumin treatment resulted in an induction of apoptosis in MDA-MB-231 cells, together with downregulation of Notch1 and its downstream target, Hes1. This reduction in Notch1 expression was determined to be due to the decreased activity of endogenous mutant p53. We confirmed the suppressive effect of curcumin on Notch1 transcription by performing a Notch1 promoter-driven reporter assay and identified a putative p53-binding site in the Notch1 promoter by EMSA and chromatin immunoprecipitation analysis. Overexpression of mutant p53 increased Notch1 promoter activity, whereas knockdown of mutant p53 by small interfering RNA suppressed Notch1 expression, leading to the induction of cellular apoptosis. Moreover, curcumin-induced apoptosis was further enhanced by the knockdown of Notch1 or mutant p53, but it was decreased by the overexpression of active Notch1. Taken together, our results demonstrate, for the first time, that Notch1 is a transcriptional target of mutant p53 in breast cancer cells and suggest that the targeting of mutant p53 and/or Notch1 may be combined with a chemotherapeutic strategy to improve the response of breast cancer cells to curcumin.
